Related Experiment Video
Updated: Jun 21, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Remodeling rodent models to mimic human type 1 diabetes
Matthias von Herrath1, Gerald T Nepom
1Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, UCSD, La Jolla, CA 92037, USA. matthias@liai.org
European Journal of Immunology
|August 13, 2009
Summary
Type 1 diabetes (T1D) research relies on animal models to study immune attacks on pancreatic beta cells. This review evaluates existing models and proposes new systems to improve understanding and treatment of T1D in humans.
Area of Science:
- Immunology
- Endocrinology
- Diabetology
Background:
- Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells.
- Animal models are crucial for understanding T1D pathogenesis and testing therapies.
- Existing models have limitations in predicting human T1D outcomes.
Purpose of the Study:
- To critically evaluate current animal models for Type 1 diabetes.
- To assess the predictive value of these models for human T1D.
- To propose novel in vitro and in vivo systems for advancing T1D research.
Main Methods:
- Literature review and critical analysis of existing T1D animal models.
- Comparative assessment of model relevance to human T1D.
- Identification and proposal of new research systems.
Main Results:
- Current animal models offer insights but have limitations in human T1D prediction.
- Genetic susceptibility, hyperglycemia progression, and therapeutic responses vary across models.
- New in vitro and in vivo systems are needed for better T1D translation.
Conclusions:
- Careful selection and validation of animal models are essential for T1D research.
- Development of improved in vitro and in vivo systems can accelerate T1D therapeutic discovery.
- Bridging the gap between animal models and human T1D is critical for progress.
